Advanced search    

Search: authors:"Jing Li"

7 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients

Cytometry Facility that is supported in part by award P30CA047904. Jing Li is supported by the China Scholarship Council. Financial Support: Funded by NIH grant R01 DE019727 and P50 CA097190. 1. Vermorken JB

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients

by award P30CA047904. Jing Li is supported by the China Scholarship Council. Financial Support: Funded by NIH grant R01 DE019727 and P50 CA097190. Open AccessThis article is distributed under the

PD-1/SHP-2 negatively regulate Tc1/Th1 phenotypic responses and activation of T cells in the tumor microenvironment

Jing Li 0 Robert L Ferris 1 From Society for Immunotherapy of Cancer th Annual Meeting National Harbor USA. November 0 Department of Pharmacy, School of Medicine, Tsinghua University , Beijing, China

Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment

Jing Li 1 Robert L Ferris 0 From Society for Immunotherapy of Cancer th Annual Meeting National Harbor USA. November 0 University of Pittsburgh Cancer Institute , Pittsburgh, PA , USA 1 Department of